An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Asan Medical Center, Seoul, Korea, Republic of
Uhmontpellier, Montpellier, France
Korea University Guro Hospital, Seoul, Korea, Republic of
Ain Shams University hospitals, Cairo, Egypt
The Third Hospital of Hebei Medical University, Shijiazhuang City, Hebei, China
Ainshams University Hospitals, Cairo, Egypt
The First hosptial of Qinhuangdao, Qinhuangdao, Hebei, China
Islam Morsy, Tanta, El-Gharbia Governorate, Egypt
Tanta University, Tanta, ElGharbiaa, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.